177
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Temporal Trends of the Incidence of Ischemic Heart Disease in Iran Over 15 Years: A Comprehensive Report from a Multi-Centric Hospital-Based Registry

ORCID Icon, , ORCID Icon, ORCID Icon, ORCID Icon, & show all
Pages 847-856 | Published online: 06 Aug 2020

References

  • Tehrani-Banihashemi A, Moradi-Lakeh M, El Bcheraoui C, et al. Burden of cardiovascular diseases in the Eastern Mediterranean Region, 1990–2015: findings from the Global Burden of Disease 2015 study. Int J Public Health. 2018;63(Suppl. 1):137–149.
  • Sarrafzadegan N, Mohammadifard N. Cardiovascular disease in iran in the last 40 years: prevalence, mortality, morbidity, challenges and strategies for cardiovascular prevention. Arch Iran Med. 2019;22(4):204–210.31126179
  • Sepanlou SG, Parsaeian M, Krohn KJ, et al. Disability-Adjusted Life-Years (DALYs) for 315 diseases and injuries and Healthy Life Expectancy (HALE) in Iran and its neighboring Countries, 1990–2015: findings from Global Burden of Disease Study 2015. Arch Iran Med. 2017;20(7):403–418.28745902
  • Moradi-Lakeh M, Sepanlou SG, Karimi SM, et al. Trend of socio-demographic index and mortality estimates in Iran and its neighbors, 1990–2015: findings of the Global Burden of Diseases 2015 Study. Arch Iran Med. 2017;20(7):419–428.28745903
  • Maracy MR, Isfahani MT, Kelishadi R, et al. Burden of ischemic heart diseases in Iran, 1990–2010: findings from the Global Burden of Disease study 2010. J Res Med Sci. 2015;20(11):1077–1083. doi:10.4103/1735-1995.17283226941812
  • Moran AE, Oliver JT, Mirzaie M, et al. Assessing the global burden of ischemic heart disease: part 1: methods for a systematic review of the global epidemiology of ischemic heart disease in 1990 and 2010. Glob Heart. 2012;7(4):315–329. doi:10.1016/j.gheart.2012.10.00423682350
  • Ramahi TM. Cardiovascular disease in the Asia Middle East region: global trends and local implications. Asia Pac J Public Health. 2010;22(3_suppl):83S–89S. doi:10.1177/101053951037303420566538
  • Roth GA, Abate D, Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–1788.30496103
  • Arsang-Jang S, Mansourian M, Mohammadifard N, et al. Temporal trend analysis of stroke and salt intake: a 15-year population-based study. Nutr Neurosci. 2019:1–11. doi:10.1080/1028415X.2019.1638665
  • Bahonar A, Khosravi A, Khorvash F, et al. Ten-year trend in stroke incidence and its subtypes in Isfahan, Iran during 2003–2013. Iran J Neurol. 2017;16(4):201–209.29736226
  • Sarrafzadegan N, Laatikainen T, Mohammadifard N, Fadhel I, Yach D, Puska P. “Isfahan healthy heart program”: a practical model of implementation in a developing country. Prog Prev Med. 2018;3(3):e0014.
  • Sarraf-Zadegan N, Sadri G, Malek Afzali H, et al. Isfahan healthy heart programme: a comprehensive integrated community-based programme for cardiovascular disease prevention and control. Design, methods and initial experience. Acta Cardiol. 2003;58(4):309–320. doi:10.2143/AC.58.4.200528812948036
  • Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas A-M, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents. Circulation. 1994;90(1):583–612. doi:10.1161/01.CIR.90.1.5838026046
  • Luepker RV. WHO MONICA project: what have we learned and where to go from here? Public Health Rev. 2011;33(2):373. doi:10.1007/BF03391642
  • Statistical Center of Iran. Selected Findings of National Population and Housing Census, 2011. Tehran: Vice Presidency for Strategic Planning and Supervision, Statistical Centre of Iran 2011.
  • Sarrafzadegan N, Hassannejad R, Marateb HR, et al. Correction: PARS risk charts: a 10-year study of risk assessment for cardiovascular diseases in Eastern Mediterranean Region. PLoS One. 2018;13(1):e0191379. doi:10.1371/journal.pone.019137929370204
  • Sarrafzadegan N, Oveisgharan S, Toghianifar N, Hosseini S, Rabiei K. Acute myocardial infarction in Isfahan, Iran: hospitalization and 28th day case-fatality rate. ARYA Atheroscler. 2009;5(3).
  • Huffman DA. A method for the construction of minimum-redundancy codes. Resonance. 2006;11(2):91–99. doi:10.1007/BF02837279
  • Givi M, Sarrafzadegan N, Garakyaraghi M, et al. Persian Registry Of cardioVascular diseasE (PROVE): design and methodology. ARYA Atheroscler. 2017;13(5):236–244.29371870
  • Nedkoff L, Goldacre R, Greenland M, et al. Comparative trends in coronary heart disease subgroup hospitalisation rates in England and Australia. Heart. 2019;105(17):1343–1350. doi:10.1136/heartjnl-2018-31451230948515
  • Rosamond WD, Chambless LE, Heiss G, et al. Twenty-two–year trends in incidence of myocardial infarction, coronary heart disease mortality, and case fatality in 4 US communities, 1987–2008. Circulation. 2012;125(15):1848–1857. doi:10.1161/CIRCULATIONAHA.111.04748022420957
  • Robitaille C, Dai S, Waters C. Ischemic heart disease prevalence and incidence in Canada. Can J Cardiol. 2014;30(10):S75–S76. doi:10.1016/j.cjca.2014.07.062
  • Rumana N, Kita Y, Turin TC, et al. Trend of increase in the incidence of acute myocardial infarction in a Japanese population: Takashima AMI registry, 1990–2001. Am J Epidemiol. 2008;167(11):1358–1364. doi:10.1093/aje/kwn06418381360
  • Lee CH, Cheng CL, Yang YHK, et al. Trends in the incidence and management of acute myocardial infarction from 1999 to 2008: get with the guidelines performance measures in Taiwan. J Am Heart Assoc. 2014;3(4):e001066. doi:10.1161/JAHA.114.00106625112555
  • Hong JS, Kang HC, Lee SH, Kim J. Long-term trend in the incidence of acute myocardial infarction in Korea: 1997–2007. Korean Circ J. 2009;39(11):467–476. doi:10.4070/kcj.2009.39.11.46719997542
  • Moran AE, Forouzanfar MH, Roth GA, et al. Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study. Circulation. 2014;129(14):1483–1492. doi:10.1161/CIRCULATIONAHA.113.00404224573352
  • Tunstall-Pedoe H, Kuulasmaa K, Mähönen M, Tolonen H, Ruokokoski E, Amouyel P. Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations. Lancet. 1999;353(9164):1547–1557. doi:10.1016/S0140-6736(99)04021-010334252
  • Madsen M, Davidsen M, Rasmussen S, Abildstrom SZ, Osler M. The validity of the diagnosis of acute myocardial infarction in routine statistics: a comparison of mortality and hospital discharge data with the Danish MONICA registry. J Clin Epidemiol. 2003;56(2):124–130. doi:10.1016/S0895-4356(02)00591-712654406
  • Traina MI, Almahmeed W, Edris A, Tuzcu EM. Coronary heart disease in the Middle East and North Africa: current status and future goals. Curr Atheroscler Rep. 2017;19(5):24. doi:10.1007/s11883-017-0659-928378303
  • Talaei M, Sadeghi M, Marshall T, et al. Impact of metabolic syndrome on ischemic heart disease–A prospective cohort study in an Iranian adult population: Isfahan cohort study. Nutr Metab Cardiovasc Dis. 2012;22(5):434–441. doi:10.1016/j.numecd.2010.08.00321195593
  • Hassannejad R, Kazemi I, Sadeghi M, et al. Longitudinal association of metabolic syndrome and dietary patterns: a 13-year prospective population-based cohort study. Nutr Metab Cardiovasc Dis. 2018;28(4):352–360. doi:10.1016/j.numecd.2017.10.02529458993
  • Ahmadi A, Soori H, Mehrabi Y, Etemad K, Samavat T, Khaledifar A. Incidence of acute myocardial infarction in Islamic Republic of Iran: a study using national registry data in 2012. East Mediterr Health. 2015;21(1):5–12. doi:10.26719/2015.21.1.5
  • Sarrafzadegan N, Sadeghi M, Oveisgharan S, Iranipour R. Incidence of cardiovascular diseases in an Iranian population: the Isfahan Cohort Study. Arch Iran Med. 2013;16(3):138–144. doi:013163/AIM.00423432164
  • Kuulasmaa K, Tunstall-Pedoe H, Dobson A, et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA project populations. Lancet. 2000;355(9205):675–687. doi:10.1016/S0140-6736(99)11180-210703799
  • Nouri F, Feizi A, Mohammadifard N, Sarrafzadegan N. Methods of sampling and sample size determination of a comprehensive integrated community-based interventional trial: Isfahan Healthy Heart Program. ARYA Atheroscler. 2018;14(2):58–70. doi:10.22122/arya.v14i2.148830108637
  • Sarrafzadegan N, Kelishadi R, Esmaillzadeh A, et al. Do lifestyle interventions work in developing countries? Findings from the Isfahan Healthy Heart Program in the Islamic Republic of Iran. Bull World Health Organ. 2009;87:39–50. doi:10.2471/BLT.07.04984119197403
  • Sarrafzadegan N, Kelishadi R, Pourmoghaddas M, et al. Outcomes of a comprehensive healthy lifestyle program on cardiometabolic risk factors in a developing country: the Isfahan Healthy Heart Program. Arch Iran Med. 2013;16(1):4–11. doi:013161/AIM.00423273227
  • Stirman SW, Kimberly J, Cook N, Calloway A, Castro F, Charns M. The sustainability of new programs and innovations: a review of the empirical literature and recommendations for future research. Implement Sci. 2012;7(1):17. doi:10.1186/1748-5908-7-1722417162
  • Sarrafzadegan N, Rabiei K, Wong F, et al. The sustainability of interventions of a community-based trial on children and adolescents’ healthy lifestyle. ARYA Atheroscler. 2014;10(2):107–117.25161679